Klaria Pharma Holding AB (OSTO:KLAR) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 28, 2026)


OSTO:KLAR Klaria Pharma Holding AB OSTO:KLAR
28 GF Score
Price kr0.78
GF Value kr0.33
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Klaria Pharma Holding AB Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Klaria Pharma Holding AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

OSTO:KLAR vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klaria Pharma Holding AB Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Klaria Pharma Holding AB's Margin of Safety % (DCF Earnings Based) falls into.


OSTO:KLAR
28GF Score
Klaria Pharma Holding AB OSTO:KLAR
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Klaria Pharma Holding AB (OSTO:KLAR) Overvalued in 2026?

Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued. The current stock price of kr0.78 is trading 136.4% above its estimated GF Value™ of kr0.33. GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:KLAR:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: kr0.33 vs. price of kr0.78 (136.4% above fair value)
  • GF Score™: 28/100 with 6 warning signs

No single metric tells the full story. See the OSTO:KLAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Klaria Pharma Holding AB Business Description

Other Exchanges 6FN:Germany
Address Virdings Alle 2, Uppsala, CHE, 754 50
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
28GF Score

Get the complete analysis for OSTO:KLAR

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.78
Price
kr0.33
GF Value